Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Humatrope in Turner's Syndrome
NCT00191113Phase 3Completed
- Sponsor
- Eli Lilly and Company
- Start
- Feb 1989
- Primary completion
- Dec 2007
- Modality
- Hormone, rProtein (Recombinant Protein), Biologic
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of somatropin in Turner syndrome (TS) (2 arms), sponsored by Eli Lilly and Company. Primary endpoints: Height Standard Deviation Score Change From Baseline and Height Standard Deviation Score at Final Height. Started Feb 1989; status: completed.
02
Drugs
somatropin
03
Conditions
Turner syndrome (TS)
Beyond the preview
Go deeper on NCT00191113.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00191113.